Stock Events

Stock Events

Alcon 

$71.47
273
-$0.61-0.85% 11:43 Today

Statistics

Day High
73.21
Day Low
71.2
52W High
87.64
52W Low
61.84
Volume
919,398
Avg. Volume
1,909,080
Mkt Cap
34.84B
P/E Ratio
40.6
Dividend Yield
0.5%
Dividend
0.36

Upcoming

Dividends

0.5%Dividend Yield
May 26
$0.36
May 25
$0.34
May 24
$0.26
May 23
$0.23
May 22
$0.20
10Y Growth
N/A
5Y Growth
26.67%
3Y Growth
15.35%
1Y Growth
6.98%

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.69
0.76
0.82
0.88
Expected EPS
0.8830045004
Actual EPS
N/A

Financials

9.42%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
10.4BRevenue
980MNet Income

Analyst Ratings

84.93Average Price Target
The highest estimate is 98.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
63%
Hold
38%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALC. It's not an investment recommendation.
Novartis
65
NOVN.SW
Nestle SA
55
NESN.SW
Apple
53
AAPL
Microsoft
51
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, competes in the eye health market, particularly in areas like contact lenses and surgical products similar to Alcon's offerings.
Cooper Companies
COO
Mkt Cap13.88B
The Cooper Companies operate through CooperVision and CooperSurgical, offering products that directly compete with Alcon's contact lens and eye care solutions.
Bausch Health Companies
BHC
Mkt Cap2.36B
Bausch Health Companies, through its division Bausch + Lomb, is a direct competitor in the eye health sector, offering a wide range of products from contact lenses to surgical instruments.
Novartis
NVS
Mkt Cap292.35B
Novartis, the former parent company of Alcon, continues to compete in the eye care market through its pharmaceutical products that address conditions like dry eye, retinal issues, and glaucoma.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, through its acquisition of Allergan, competes in the eye care market with products targeting conditions such as dry eye and glaucoma, directly competing with Alcon's portfolio.
Staar Surgical
STAA
Mkt Cap1.11B
STAAR Surgical specializes in ophthalmic products, particularly in implantable lenses for the eye, competing directly with Alcon's intraocular lenses and cataract surgery products.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences, while broader in focus, competes with Alcon in the surgical instruments market, particularly in tools and devices used in ophthalmic surgery.
Eco Science Solutions
ESSI
Mkt Cap26,479
EssilorLuxottica is a leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, competing with Alcon's vision care products.

About

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Show more...
CEO
David J. Endicott
Employees
25942
Country
Switzerland
ISIN
CH0432492467
WKN
000A2PDXE

Listings

MI
IT
1ALC.MI
XETRA
DE
2U3.XETRA
MX
MX
ALCN.MX
STU
DE
2U3.STU

0 Comments

Share your thoughts

FAQ

What is Alcon stock price today?▼
The current price of ALC is $71.47 USD — it has decreased by -0.85% in the past 24 hours. Watch Alcon stock price performance more closely on the chart.
What is Alcon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Alcon stocks are traded under the ticker ALC.
Is Alcon stock price growing?▼
ALC stock has risen by +0.1% compared to the previous week, the month change is a +1.54% rise, over the last year Alcon has showed a -8.66% decrease.
What is Alcon market cap?▼
Today Alcon has the market capitalization of 34.84B
When is the next Alcon earnings date?▼
Alcon is going to release the next earnings report on November 10, 2026.
What were Alcon earnings last quarter?▼
ALC earnings for the last quarter are 0.84 USD per share, whereas the estimation was 0.75 USD resulting in a +12.66% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alcon revenue for the last year?▼
Alcon revenue for the last year amounts to 10.4B USD.
What is Alcon net income for the last year?▼
ALC net income for the last year is 980M USD.
Does Alcon pay dividends?▼
Yes, ALC dividends are paid annual. The last dividend per share was 0.36 USD. As of today, Dividend Yield (FWD)% is 0.5%.
How many employees does Alcon have?▼
As of September 04, 2026, the company has 25,942 employees.
In which sector is Alcon located?▼
Alcon operates in the Health & Wellness sector.
When did Alcon complete a stock split?▼
The last stock split for Alcon was on June 16, 2011 with a ratio of 2:1.
Where is Alcon headquartered?▼
Alcon is headquartered in Geneva, Switzerland.